Opendata, web and dolomites

ERA-CVD SIGNED

ERA-NET on cardiovascular diseases to implement joint transnational research projects and set up international cooperations

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "ERA-CVD" data sheet

The following table provides information about the project.

Coordinator
DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV 

Organization address
address: Linder Hoehe
city: KOELN
postcode: 51147
website: www.dlr.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 19˙103˙750 €
 EC max contribution 5˙974˙237 € (31%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-HCO-2015
 Funding Scheme ERA-NET-Cofund
 Starting year 2015
 Duration (year-month-day) from 2015-10-01   to  2021-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV DE (KOELN) coordinator 23˙925.00
2    BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG DE (BONN) participant 1˙137˙675.00
3    AGENCE NATIONALE DE LA RECHERCHE FR (PARIS) participant 802˙312.00
4    MINISTERO DELLA SALUTE IT (ROMA) participant 616˙687.00
5    NEDERLANDSE HARTSTICHTING NL (S GRAVENHAGE) participant 431˙062.00
6    TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU TR (ANKARA) participant 356˙812.00
7    FONDS ZUR FÖRDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG AT (WIEN) participant 245˙437.00
8    INSTITUTO DE SALUD CARLOS III ES (MADRID) participant 245˙437.00
9    NARODOWE CENTRUM BADAN I ROZWOJU PL (WARSZAWA) participant 245˙437.00
10    NORGES FORSKNINGSRAD NO (OSLO) participant 245˙437.00
11    FUNDACAO PARA A CIENCIA E A TECNOLOGIA PT (LISBOA) participant 208˙312.00
12    MINISTERUL EDUCATIEI SI CERCETARII RO (BUCURESTI) participant 171˙187.00
13    VALSTS IZGLITIBAS ATTISTIBAS AGENTURA LV (RIGA) participant 171˙187.00
14    ZORGONDERZOEK NEDERLAND ZON NL (DEN HAAG) participant 152˙625.00
15    MINISTRY OF HEALTH IL (JERUSALEM) participant 148˙912.00
16    Ministrstvo za izobrazevanje, znanost in sport SI (Ljubljana) participant 137˙775.00
17    FONDS DE LA RECHERCHE SCIENTIFIQUE- FNRS BE (BRUXELLES) participant 134˙062.00
18    FONDS VOOR WETENSCHAPPELIJK ONDERZOEK-VLAANDEREN BE (BRUSSEL) participant 134˙062.00
19    SLOVENSKA AKADEMIA VIED SK (BRATISLAVA) participant 104˙362.00
20    MINISTERIO DA SAUDE - REPUBLICA PORTUGUESA PT (LISBOA) participant 96˙937.00
21    SIHTASUTUS EESTI TEADUSAGENTUUR EE (TARTU) participant 96˙937.00
22    NASJONALFORENINGEN FOR FOLKEHELSEN NO (OSLO) participant 67˙650.00
23    AUTORITATEA NATIONALA PENTRU CERCETARE STIINTIFICA SI INOVARE RO (Bucuresti) participant 0.00
24    MINISTRY OF SCIENCE AND TECHNOLOGY TW (Taipei) participant 0.00

Map

 Project objective

Cardiovascular diseases (CVD) are the largest cause of death in the EU and account for around 2 million deaths per year. Overall, CVD are estimated to cause the economy of the EU costs of almost 196 billion Euros a year. Furthermore, they are one of the leading causes of long term sickness, chronic diseases and loss to the labour market. Therefore, CVD are a major health problem in Europe. Despite the overall burden of CVD on European citizens and national health systems, translational cardiovascular research is fragmented and mainly occurs at national levels. However, the present and future challenges in cardiovascular research can only be met by an effective cooperation at transnational level. Therefore, the proposed European Research Area Network on cardiovascular diseases (ERA-CVD) aims to coordinate national and regional programmes for translational research in the area CVD by implementing one Joint Transnational Call (JTC2016) with EU Co-funding followed by further non-co-funded JTC (2017-2019). Although this consortium will be newly established, a collaboration and alignment of national programmes and activities has already been achieved during the preparation of the ERA-Net Co-fund proposal. This process is supported by CardioScape an EU-funded survey of the European cardiovascular research landscape coordinated by the European Society of Cardiology (ESC). The current ERA-CVD proposal will extend and strengthen the transnational cooperation of the current 23 ministries/institutions/foundations from 18 European, associated and third countries. Furthermore, ERA-CVD plans to cooperate with the ESC and the European Heart Network (EHN). Moreover, the collaboration with European Research Infrastructures, e.g. the ESFRI-initiatives is intended in order to set up an efficient European framework for innovative transnational research on CVD. Also the extension of the consortium and international collaborations are intended.

 Deliverables

List of deliverables.
Public Call documents for JTC2016: Call text, guidelines for applicants, proposal templates, electronic submission tool Documents, reports 2020-04-06 10:04:23

Take a look to the deliverables list in detail:  detailed list of ERA-CVD deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ERA-CVD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ERA-CVD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

SBR (2020)

SMART BONE REGENERATION

Read More  

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More